 Syros Pharmaceuticals, Inc. NASDAQ:SYRS Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Courtney Solberg - Manager, Corporate Communications and IR Nancy Simonian - CEO Jason Haas - CFO David Roth - Chief Medical Officer Kristin Stephens - Chief Development Office Eric Olson - Chief Scientific Officer Conley Chee - Chief Commercial Officer Conference Call Participants Ted Tenthoff - Piper Sandler Eva Previtera - Cowen Jason Butler - JMP Securities Mark Breidenbach - Oppenheimer Zegbeh Jallah - ROTH Capital Partners Matthew Cross - Alliance Global Partners Operator Good morning and welcome to Syros Pharmaceuticals First Quarter 2022 Financial Results Conference Call. At this time, all participants are in listen-only mode. 